5-aza-2'-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line.
Head and neck cancer squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, resulting in over 600,000 new diagnoses annually. Traditionally, HNCC has been related to tobacco and alcohol exposure; however, over the past decade, a growing number of head and neck cancers are attribu...
Enregistré dans:
Auteurs principaux: | Reem Miari, Naiel Azzam, Rinat Bar-Shalom, Fuad Fares |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b430855ecdfd4a69a64f2089b07ee6e9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
In vitro cytotoxicity of GO–DOx on FaDu squamous carcinoma cell lines
par: Singh M, et autres
Publié: (2018) -
HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.
par: Guolin Chai, et autres
Publié: (2008) -
Significant transcriptomic changes are associated with the inhibitory effects of 5-aza-2-deoxycytidine during adipogenic differentiation of MG-63 cells
par: Amir Ali Khan, et autres
Publié: (2021) -
FADU: a Quantification Tool for Prokaryotic Transcriptomic Analyses
par: Matthew Chung, et autres
Publié: (2021) -
Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
par: Treewut Rassamegevanon, et autres
Publié: (2021)